The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
Open accessAbstract
The unique metabolism of most solid tumours (aerobic glycolysis, i.e., Warburg effect) is not only the basis of diagnosing cancer with metabolic imaging but might also be associated with the resistance to apoptosis that characterises cancer. The glycolytic phenotype in cancer appears to be the common denominator of diverse molecular abnormalities in cancer and may be associated with a (potentially reversible) suppression of mitochondrial function. The generic drug dichloroacetate is an orally available small molecule that, by inhibiting the pyruvate dehydrogenase kinase, increases the flux of pyruvate into the mitochondria, promoting glucose oxidation over glycolysis. This reverses the suppressed mitochondrial apoptosis in cancer and results in suppression of tumour growth in vitro and in vivo. Here, we review the scientific and clinical rationale supporting the rapid translation of this promising metabolic modulator in early-phase cancer clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 3×
“This hypothesis is also supported by the recently published work that inhibition of LDH (by siRNA), which promotes the transfer of pyruvate into the mitochondria (in that sense mimicking DCA), also promotes cancer apoptosis and decreases tumour growth in vitro and in mice xenotransplants (”
BackgroundInfluentialBonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Self-citationAkt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Cancer's Molecular Sweet Tooth and the Warburg Effect
Kim, J.-W., & Dang, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1501 · Cited by 1,215
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037
The mitochondrion in apoptosis: how Pandora's box opens
Zamzami, N., & Kroemer, G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048073 · Cited by 1,028
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961
Xu, R.-H., Pelicano, H., Zhou, Y., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., & Huang, P. (2005) · Cancer Research · doi:10.1158/0008-5472.613.65.2 · Cited by 835
Multifaceted roles of glycolytic enzymes
Kim, J.-W., & Dang, C. V. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.005 · Cited by 682
The pharmacology of dichloroacetate
Stacpoole, P. W. (1989) · Metabolism · doi:10.1016/0026-0495(89)90051-6 · Cited by 484
Sugden, M. C., & Holness, M. J. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00526.2002 · Cited by 428
Matrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen
Xu, X., Wang, Y., Chen, Z., Sternlicht, M. D., Hidalgo, M., & Steffensen, B. (2005) · Cancer Research · doi:10.1158/0008-5472.130.65.1 · Cited by 413
Pastorino, J. G., Hoek, J. B., & Shulga, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1925 · Cited by 398
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
Kaufmann, P., Engelstad, K., Wei, Y., Jhung, S., Sano, M. C., Shungu, D. C., Millar, W. S., Hong, X., Gooch, C. L., Mao, X., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000196641.05913.27 · Cited by 365
Why is cancer drug discovery so difficult?
Kamb, A., Wee, S., & Lengauer, C. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2155 · Cited by 339
Controlled Clinical Trial of Dichloroacetate for Treatment of Congenital Lactic Acidosis in Children
Stacpoole, P. W., Kerr, D. S., Barnes, C., Bunch, S. T., Carney, P. R., Fennell, E. M., Felitsyn, N. M., Gilmore, R. L., Greer, M., Henderson, G. N., et al. (2006) · Pediatrics · doi:10.1542/peds.2005-1226 · Cited by 259
Activation of K+channels: an essential pathway in programmed cell death
Remillard, C. V., & Yuan, J. X.-J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2003 · Cited by 251
Halestrap, A. (2005) · Nature · doi:10.1038/434578a · Cited by 239
Cell metabolism in the regulation of programmed cell death
Plas, D. R., & Thompson, C. B. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00528-8 · Cited by 232
Glucose Catabolism in Cancer Cells
Mathupala, S. P., Heese, C., & Pedersen, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22776 · Cited by 231
Glucose Catabolism in Cancer Cells.
Mathupala, S. P., Rempel, A., & Pedersen, P. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16918 · Cited by 229
Dichloroacetate induces apoptosis in endometrial cancer cells
Wong, J. Y. Y., Huggins, G. S., Debidda, M., Munshi, N. C., & De Vivo, I. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.038 · Cited by 219
Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy
Cairns, R. A., Papandreou, I., Sutphin, P. D., & Denko, N. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611662104 · Cited by 182
Cao, W., Yacoub, S., Shiverick, K. T., Namiki, K., Sakai, Y., Porvasnik, S., Urbanek, C., & Rosser, C. J. (2008) · The Prostate · doi:10.1002/pros.20788 · Cited by 181
Efficacy of Dichloroacetate as a Lactate-Lowering Drug
Stacpoole, P. W., Nagaraja, N. V., & Hutson, A. D. (2003) · Journal of Clinical Pharmacology · doi:10.1177/0091270003043007001 · Cited by 171
Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?
Pan, J. G., & Mak, T. W. (2007) · Science s STKE · doi:10.1126/stke.3812007pe14 · Cited by 147
Effects of dichloroacetate infusion on human skeletal muscle metabolism at the onset of exercise
Howlett, R. A., Heigenhauser, G. J. F., Hultman, E., Hollidge-Horvat, M. G., & Spriet, L. L. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e18 · Cited by 121
Effects of PDH activation by dichloroacetate in human skeletal muscle during exercise in hypoxia
Parolin, M. L., Spriet, L. L., Hultman, E., Matsos, M. P., Hollidge-Horvat, M. G., Jones, N. L., & Heigenhauser, G. J. F. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e752 · Cited by 64
Dichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS
Mori, M., Yamagata, T., Goto, T., Saito, S., & Momoi, M. Y. (2004) · Brain and Development · doi:10.1016/j.braindev.2003.12.009 · Cited by 43
Review of the Pharmacologic and Therapeutic Effects of Diisopropylammonium Dichloroacetate (DIPA)
Stacpoole, P. W. (1969) · The Journal of Clinical Pharmacology · doi:10.1177/009127006900900502 · Cited by 35
Cited by
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Cárdenas, C., Miller, R. A., Smith, I., Bui, T., Molgó, J., Müller, M., Vais, H., Cheung, K.-H., Yang, J., Parker, I., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.007 · Cited by 1,026
“Importantly, inhibition of PDH kinases in KO cells by dichloroacetic acid (DCA, 2 mM) (Michelakis et al., 2008) reduced PDH phosphorylation (Figure 7C), restored OCR (Figure 7D), and reduced autophagy (Figure 7E) to control levels.”
Targeting cellular metabolism to improve cancer therapeutics
Zhao, Y., Butler, E. B., & Tan, M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.60 · Cited by 989
Metadata
- Authors
- Michelakis, E. D., Webster, L., & Mackey, J. R.
- Venue
- British Journal of Cancer
- Published
- 2008-09-02
- Volume
- 99
- Issue
- 7
- Pages
- 989-994
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2018971639
- Cited by
- 656
- References
- 33
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.